Table 1.

Characteristics of Participants

	Total	Phase 2 - treatment	Phase 2 - placebo
Total Participants	77	26	15
Male	69	24	14
Female	8	2	1
Age (years)	6.3	6.7	6.5
Diagnosis	95% autism, 3% PDD/NOS, 3% Asperger's	96% Autism, 4% Aspergers	100% Autism